CETP B1 | NOS3 T | Total CAD patients n(%) ORs (95% CI) n = 207 | CAD with T2DM n(%) ORs (95% CI) n = 102 | CAD without T2DM n(%) ORs (95% CI) n = 105 | T2DM patients n(%) ORs (95% CI) n = 101 | Controls n(%) n = 92 |
---|---|---|---|---|---|---|
− | − | 3 (1.4) | 2 (2) | 1 (1) | 2 (2) | 8 (8.7) |
− | + | 3 (1.4) | 3 (2.9) | 0 | 2 (2) | 12 (13) |
0.67 (0.11–4.17, p = 0.67) | 1 (0.14–7.4, p = 1) | 0.67 (0.1–5.7, p = 0.71) | ||||
+ | − | 113 (54.6) | 53 (52) | 60 (57.1) | 58 (57.4) | 59 (64.2) |
5.1 (1.3–20, p = 0.019) | 3.6 (0.73–17.7, p = 0.11) | 8.14 (1–67, p = 0.05) | 3.9 (0.8–19.3, p = 0.09) | |||
+ | + | 88 (42.6) | 44 (43.1) | 44 (41.9) | 39 (38.6) | 13 (14.1) |
18.1 (4.2–76.8, p < 0.001) | 13.5 (2.6–71.8, p = 0.002) | 27.1 (3.1–237, p = 0.003) | 12 (2.25–63.8, p = 0.004) |